Keywords: cadila, antiulcerant, rabeloc, gains, approval, india, pharmaceuticals

Cadila's antiulcerant Rabeloc gains approval in India.

Article | 21 January 2002

Cadila Pharmaceuticals has received approval from the Indianregulatory authorities to market the antiulcerant rabeprazole sodium. The firm planned to roll ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eisai

Go to company listing

Related Drugs

Aciphex

Rabeprazole Sodium

Go to drug listing